文献速递分子诊断质量管理与危急值临床微生物

基孔肯雅热疫情期间虫媒病毒假病毒参考品与全国室间质评的建立

Establishment of Pseudovirus-Based Reference Materials and Nationwide External Quality Assessment for Arboviruses during the 2025 Chikungunya Outbreak.
PubMed 文献 · Clin Chem · 2026-01-01

研究开发了基孔肯雅病毒、登革病毒和寨卡病毒的假病毒RNA参考品,经9家实验室用数字PCR定值,并与WHO国际标准及临床样本验证互换性。依托该参考品,中国开展了首个全国性虫媒病毒核酸检测室间质评,覆盖31个省份937家实验室、51种扩增试剂盒,超过97.5%的实验室获得满分、超过99%合格,同时暴露出机构间检测范围与性能差异、血站混样检测漏检低浓度CHIKV及试剂依赖性Ct值与扩增效率差异等问题。

要点

  • 三种假病毒RNA参考品获国家正式批准,可用于虫媒病毒核酸检测标准化。
  • 全国937家实验室室间质评中超过99%合格,但低浓度CHIKV与DENV-2检测受试剂影响明显。
  • 血站混样检测会漏检低水平CHIKV,需关注检测策略的灵敏度缺口。

核心结论

  • 标准化参考品结合全国室间质评可暴露实验室间与试剂间的隐藏不一致性,为诊断一致化提供框架。

研究设计与样本

  • 研发CHIKV、DENV、ZIKV假病毒RNA参考品,每种病毒由9家实验室用数字PCR定值,并验证稳定性及与WHO国际标准和临床样本的互换性;随后开展全国虫媒病毒核酸室间质评,覆盖31个省份937家实验室、51种扩增试剂盒。

主要发现

  • 三种参考品获中国国家市场监督管理总局批准,CHIKV、DENV、ZIKV对应编号分别为GBW(E)091403、GBW(E)091405、GBW(E)091409。
  • 超过97.5%的实验室获满分、超过99%合格。
  • 质评发现机构间检测范围与性能存在差异,血站混样检测漏检低浓度CHIKV,试剂依赖性Ct值与扩增效率差异为78.9%至146.4%,影响低浓度CHIKV和DENV-2检测。

关键数值与推荐

  • 参考品浓度经9家实验室数字PCR定值,并与WHO国际标准及临床样本验证互换性。
  • 室间质评使用51种扩增试剂盒,覆盖31个省份937家实验室。
  • 扩增效率范围为78.9%至146.4%。

临床怎么用

  • 实验室可借助此类参考品和全国室间质评结果识别自身检测范围与试剂性能短板,优化低浓度虫媒病毒检测策略。

局限性

  • 原文未在摘要中报告参考品定值的不确定度、质评样本的具体浓度水平及各试剂盒的逐项性能数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Emerging arboviruses such as chikungunya virus (CHIKV), dengue virus (DENV), and Zika virus (ZIKV) pose growing public health challenges, demanding reliable diagnostic systems to support outbreak responses. During the July 2025 CHIKV outbreak in China, the absence of domestic nucleic acid reference materials (RMs) and external quality assessment (EQA) programs hindered diagnostic standardization. METHODS: We developed pseudovirus-based RNA RMs for CHIKV, DENV, and ZIKV and certified their concentrations using digital PCR across 9 laboratories for each virus, ensuring stability and commutability with WHO international standards and clinical samples. Leveraging these RMs, China conducted its first nationwide arbovirus nucleic acid EQA program. RESULTS: All three RMs were officially approved by China's State Administration for Market Regulation, with codes GBW(E)091403, GBW(E)091405, and GBW(E)091409 for CHIKV, DENV, and ZIKV, respectively. The EQA program involved 937 laboratories across 31 provinces and employed 51 amplification kits. Over 97.5% of laboratories achieved perfect scores and >99% were qualified, reflecting strong overall testing capacity. Crucially, the EQA revealed systematic gaps: institutional differences in testing scope and performance were evident, pooled testing in blood stations missed low CHIKV levels, and reagent-dependent differences in Cycle threshold values and amplification efficiency (78.9% to 146.4%) affected low-concentration CHIKV and DENV-2 detection. CONCLUSIONS: These findings underscore the power of large-scale EQA to expose hidden inter-laboratory and reagent inconsistencies. By integrating standardized RMs with nationwide EQA, this work provides a robust framework for diagnostic harmonization, drives quality improvement, and strengthens preparedness for future arboviral threats.

来源:Clin Chem,查看原文。版权归原作者所有。

引用

  1. Yan Y, Liu X, Halemubieke S, et al. Establishment of Pseudovirus-Based Reference Materials and Nationwide External Quality Assessment for Arboviruses during the 2025 Chikungunya Outbreak. Clin Chem. 2026. PMID: 42271626. doi:10.1093/clinchem/hvag050

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。